| Ms Lois A Fink, LMHC | |
|
111 10th St Sw, Waverly, IA 50677-2925 | |
| (319) 352-2064 | |
| (319) 352-2329 |
| Full Name | Ms Lois A Fink |
|---|---|
| Gender | Female |
| Speciality | Counselor - Mental Health |
| Location | 111 10th St Sw, Waverly, Iowa |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053484246 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YM0800X | Counselor - Mental Health | 00327 (Iowa) | Primary |
| Entity Name | Pathways Behavioral Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114950979 PECOS PAC ID: 3779582796 Enrollment ID: O20061220000159 |
News Archive
When a patient is prescribed the wrong antibiotic to treat a bacterial infection, it's not necessarily the physician who is at fault. The current antibiotic assay - standardized in 1961 by the World Health Organization and used worldwide - is potentially flawed.
MoFlo Astrios EQ, a six-way jet-in-air sorter from Beckman Coulter Life Sciences, delivers patent pending enhanced dual forward scatter (eFSC) technology for simultaneous sorting and detection of particles from 200 nm to 30 µm in diameter. The instrument sets a new standard for flow cytometry core facilities, delivering high-speed cell sorting and micro-particle detection in a single package. Featuring detailed and precise forward scatter resolution, beadless drop sample handling and increased biosafety, Astrios EQ meets a range of analysis needs.
Predicting genes that can cause disease due to the production of truncated or altered proteins that take on a new or different function, rather than those that lose their function, is now possible thanks to an international team of researchers, including researchers from Baylor College of Medicine, that has developed a new analytical tool to effectively and efficiently predict such candidate genes.
RXi Pharmaceuticals Corporation, a recognized leader in RNAi-based therapeutic discovery and development, today reported its financial results for the third quarter ended September 30, 2010.
Oregon regulators rejected calls to push back the cancellation dates of 140,000 health insurance policies in the state, even as momentum to delay the cancellations builds among California officials and some national Democratic figures. Meanwhile, PBS Newshour explores the reasons for the cancellations of policies which are sold directly to individuals.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ms Lois A Fink, LMHC 111 10th St Sw, Waverly, IA 50677-2925 Ph: (319) 352-2064 | Ms Lois A Fink, LMHC 111 10th St Sw, Waverly, IA 50677-2925 Ph: (319) 352-2064 |
News Archive
When a patient is prescribed the wrong antibiotic to treat a bacterial infection, it's not necessarily the physician who is at fault. The current antibiotic assay - standardized in 1961 by the World Health Organization and used worldwide - is potentially flawed.
MoFlo Astrios EQ, a six-way jet-in-air sorter from Beckman Coulter Life Sciences, delivers patent pending enhanced dual forward scatter (eFSC) technology for simultaneous sorting and detection of particles from 200 nm to 30 µm in diameter. The instrument sets a new standard for flow cytometry core facilities, delivering high-speed cell sorting and micro-particle detection in a single package. Featuring detailed and precise forward scatter resolution, beadless drop sample handling and increased biosafety, Astrios EQ meets a range of analysis needs.
Predicting genes that can cause disease due to the production of truncated or altered proteins that take on a new or different function, rather than those that lose their function, is now possible thanks to an international team of researchers, including researchers from Baylor College of Medicine, that has developed a new analytical tool to effectively and efficiently predict such candidate genes.
RXi Pharmaceuticals Corporation, a recognized leader in RNAi-based therapeutic discovery and development, today reported its financial results for the third quarter ended September 30, 2010.
Oregon regulators rejected calls to push back the cancellation dates of 140,000 health insurance policies in the state, even as momentum to delay the cancellations builds among California officials and some national Democratic figures. Meanwhile, PBS Newshour explores the reasons for the cancellations of policies which are sold directly to individuals.
› Verified 1 days ago
Mrs. Amanda Joan Gesme, LMHC, ATR-BC, NCC Counselor Medicare: Medicare Enrolled Practice Location: 111 10th St Sw, Waverly, IA 50677 Phone: 319-352-2064 Fax: 319-352-2329 | |
Julie R Kneip, Counselor Medicare: Not Enrolled in Medicare Practice Location: 609 4th Ave Sw, Waverly, IA 50677 Phone: 319-429-1301 | |
Ashley Petersen, Counselor Medicare: Not Enrolled in Medicare Practice Location: 106 16th St Sw, Waverly, IA 50677 Phone: 319-352-2630 | |
Angela Christine Hjelmeland, Counselor Medicare: Not Enrolled in Medicare Practice Location: 506 E Bremer Ave, Waverly, IA 50677 Phone: 319-559-1065 Fax: 319-575-6065 | |
Vicky Kukral, LMHC Counselor Medicare: Not Enrolled in Medicare Practice Location: 106 16th St Sw, Waverly, IA 50677 Phone: 319-352-2630 Fax: 319-352-0773 | |
Mrs. Amy Susan Roling, LMHC, NCC Counselor Medicare: Not Enrolled in Medicare Practice Location: 118 1 Street Sw, Waverly, IA 50677 Phone: 319-269-8948 |